Why the study?
Are changes in clinical characteristics and management over a 15-year period associated with improved 30-day survival in patients with STEMI?
Are changes in clinical characteristics and management over a 15-year period associated with improved 30-day survival in patients with STEMI?
Over a 15-year period in France, 30-day mortality for STEMI significantly decreased, driven by changes in patient characteristics and increased use of reperfusion therapy and recommended medications.
No takes yet. Share an insight, caveat, or question.
STEMI 30-day mortality declined over 15 years; extends observational associations with reperfusion and medications but leaves causality open.
Étienne Puymirat (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: